NCT03134118 2026-05-15NIVOTHYMEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Active not recruiting55 enrolled
NCT03583086 2024-10-08Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic TumorsVanderbilt-Ingram Cancer CenterPhase 1/2 Completed88 enrolled 20 charts